Meanwhile, CD163+ TAMs are also known to be associated with epithelial–mesenchymal transition (EMT), the mesenchymal circulating tumor cell ratio, and a poor prognosis of CRC [51], in accordance with this present study. This evidence concerns the gene CD163 and colorectal carcinoma.